Ingevity Corp

NYSE:NGVT

Earnings Call Analysis

Mixed Quarterly Performance with Repositioning Efforts

Ingevity's second quarter saw sales decline 19% to $390.6 million, driven by repositioning in Performance Chemicals and weaker industrial demand. Performance Materials achieved over 50% EBITDA margins for the fourth consecutive quarter. Advanced Polymer Technologies saw volume growth but faced pricing pressures. The company faced $386 million in non-operating charges, leading to a GAAP net loss of $283.7 million. Free cash flow expectations shifted to slightly positive for the full year after including a $100 million CTO contract termination fee. Full-year sales guidance was revised to $1.4-$1.5 billion, with adjusted EBITDA between $350-$360 million, aiming for mid-20% margins and over $150 million in annual free cash flow by 2025.

Company Overview

Ingevity has had a challenging quarter, marked by significant shifts in its Performance Chemicals segment. The company is positioning itself for long-term stability and profitability by focusing on higher-margin, less capital-intensive operations. This adjustive journey began last fall with the closure of the DeRidder facility and has now evolved to include the termination of their CTO supply contract, which had been a substantial cash outflow.

Financial Performance

For Q2 2024, Ingevity reported sales of $390.6 million, a significant decrease of 19% mainly due to repositioning actions within Performance Chemicals and weak industrial demand. Despite these challenges, adjusted EBITDA margins increased 80 basis points to 26%, demonstrating resilience in the company's core portfolio. However, a noncash goodwill impairment charge of $349 million greatly impacted the overall GAAP net loss, which totaled $283.7 million.

Performance by Segment

The Performance Materials segment performed well, showing a year-over-year sales increase of 9% to $157.2 million and EBITDA growth of 28%, maintaining an impressive EBITDA margin of 52.3%. Conversely, Performance Chemicals faced a drastic sales decline of 35%, adversely impacted by weather-related construction delays and a shift away from low-margin end markets, with adjustments made to growth expectations reflecting these tough market conditions.

Outlook and Guidance

Ingevity is revising its full-year sales forecast to between $1.4 billion and $1.5 billion, alongside adjusted EBITDA expectations of $350 million to $360 million. This reflects the company's cautious view on the industrial market, road construction opportunities, and the increasing costs associated with its operations. The optimism regarding recovery in this sector is tempered by external economic factors and adverse weather that has already impacted performance.

Cost Structure Improvements

The company aims to achieve substantial cost structure improvements following the closure of its Crossett plant, projected to save between $30 million to $35 million annually beginning in 2025. These savings will contribute to Ingevity's goal of generating over $150 million in free cash flow in the near future, allowing for debt reduction and potential cash returns to shareholders.

Managing Challenges Ahead

Ingevity will continue to deal with high costs associated with CTO procurement until it transitions to market pricing, expected to be roughly half of the current rates by Q2 2025. This transition is vital for restoring profitability in the Performance Chemicals segment, especially as the company has forecasted that EBITDA in this segment will break even by the end of 2024 with a return to profitability anticipated in 2025.

Earnings Call Transcript 2024-Q2

[Operator]

Good morning, all, and thank you all for attending the Ingevity second quarter 2024 earnings call and webcast. My name is Brika and I will be your moderator today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end.

I would now like to pass the conference over to your host, John Nypaver from Ingevity to begin. So you may proceed, John.

[John Nypaver, executive]

Thank you, Brika. Good morning, and welcome to Ingevity's second quarter 2024 earnings call. Earlier this morning, we posted a presentation on our investor site that you can use to follow today's discussion. It can be found on ir.ingevity.com under Events and Presentations.

Also, throughout this call, we may refer to non-GAAP financial measures, which are intended to supplement, not substitute for comparable GAAP measures. Definitions of these non-GAAP financial measures and reconciliations to comparable GAAP measures are included in our earnings release and are also in our most recent Form 10-K.

We may also make forward-looking statements regarding future events and future financial performance of the company during this call. And we caution you that these statements are just projections and actual results or events may differ materially from those projections as further described in our earnings release.

Our agenda is on Slide 3. Our speakers today are John Fortson, our President and CEO; and Mary Dean Hall, our CFO. Our business leads Ed Woodcock, President of Performance Materials; Rich White, President of Performance Chemicals; and Steve Hulme, President of Advanced Polymer Technologies are available for questions and comments.

John will start us off with some highlights for the quarter and an update on our repositioning efforts in Performance Chemicals. Mary will follow with a review of our consolidated financial performance and the business segment results for the second quarter. John will then provide closing comments and discuss 2024 guidance.

With that, over to you, John.

[John Fortson, executive]

Thanks, John. And hello, everyone. There's lots to talk about in this call. As you have no doubt seen, we announced further repositioning of our Performance Chemicals segment, a process that started last fall with the closure of our DeRidder, Louisiana facility. Mary and I will speak in detail about what we have done, why and where we are going.

These recent actions, the termination of the CTO supply contract, the goodwill impairment and the relocation of our oleo refining to Charleston are important milestones to move the PC segment forward and get these issues behind us to create a stronger, more stable PC segment for 2025 and beyond.

First, though, let us address the quarter. Turning to Slide 4, overall, it was a mixed quarter. I'll start with highlighting Performance Materials, who for the first time ever delivered a fourth straight quarter at 50% plus EBITDA margins. Most simply, the value we get in the market for our products, lower production costs and increased hybrid adoption are more than offsetting both soft auto production and full BEV vehicle market penetration.

Macro trends continue to benefit the segment as hybrids and ICE vehicles are making up a larger mix of autos being produced. And while the cost of energy improved versus last year, what is helping the segment maintain these margins is our plants are using less energy due to operational efficiencies the team has implemented. Both the commercial team and the operations team are ensuring this segment continues to fire on all cylinders.

Advanced Polymer Technologies saw a third straight quarter of volume growth and year-over-year volumes were up as well. We see encouraging signs in end markets such as electronics and auto, which is driving higher demand for Capa encodings and high-performing adhesives. Year volumes have begun to bounce back. However, China, and to some extent the U.S., continues to be impacted by slower industrial demand. The team is focusing on markets where Capa's value proposition helps maximize profitability in a dynamic environment and they continue to deliver 20% margins.

In Performance Chemicals, the quarter's results were impacted by our reduced exposure to certain end markets as part of our repositioning efforts. Several other factors were at work as well. The first was weather. As you may have heard from other companies, there was a lot of rain across the country in May. You can't pave or do road markings when it rains, so the quarter got off to a slow start.

We estimate we missed about 2 weeks' worth of sales due to this rain. In fact, July was wet as well due to the hurricane reaching landfall in Texas. If the weather improves and holds up the rest of the summer and well into the fall, we can get those sales back. But road construction projects are weather-dependent, so we'll see. We are confident, however, that the pavers, if they can, will work as hard as possible to make up for this lost time.

Second, a weaker than anticipated industrial market recovery has impacted the Industrial Specialties product lines. In the quarter, revenue from our non-CTO, oleo-based products was up versus last year, but the pace of this growth is slower than we'd like. Finally, the price we paid for CTO in the quarter remained elevated and this negatively impacted the segment's profitability.

Let's turn to Slide 5 and we will discuss CTO in more detail. A few weeks ago, we announced the termination of our final long-term CTO supply agreement. This was a critical step to move as quickly as possible to a market cost for CTO, as the price we had been paying was well in excess of what we and our competitors could source in the open market. This creates a clear path for the PC business to improve its profitability and put an end to the negative cash drain these purchases were creating.

We said on our last quarterly call that we expected the CTO price we pay under our long-term supply contract to moderate in the second half of the year. But during the quarter, we were informed that the contracted price in the second half would be much higher than expected.

As we have discussed before, when we closed our DeRidder, Louisiana facility, our remaining long-term supply contract required us to continue buying CTO earmarked at that facility for a 2-year wind-down period, leaving us with excess CTO. We were reselling that excess CTO at forecasted losses of $50 million to $80 million in 2024.

We expected that our contract prices would come down in the second half of 2024 and throughout 2025 and those resale losses would narrow. However, it became apparent that this would not be the case in the foreseeable future. Therefore, we negotiated a buyout of the contract for $100 million, payable in 2 $50 million installments.

Effective July 1st, we are no longer obligated to take CTO from any long-term contracts. We have enough CTO on hand and available via short-term deals to cover our needs to the first quarter of 2025 and we believe there are enough available options in the market to meet our needs next year and beyond.

We will still feel the impact of this higher price CTO on this PC segment's P&L through the remainder of this year and until the end of the first quarter of 2025 as we work through the higher cost inventory we have on hand. However, after that point, we will be purchasing and using CTO that we acquire in the open market. While painful, this was an important step for the business to move forward and return to profitability and cash generation. Mary will provide more detail on the impacts to our financial statements in a few minutes.

Now please turn to Slide 6. In order to reduce our cost structure, we are transferring the refining of oleo-based raw materials to our North Charleston facility. This will result in the closure of our Crossett, Arkansas site. A key tenet of our growth strategy and Performance Chemicals is to diversify our raw material streams and grow our oleo-based penetration into our legacy markets while also developing new market opportunities for these oleo-based products.

This has not changed. Operationally, we've proven the fatty acids we make from soy and canola work and in fact, we've made great progress in using them as substitutes in existing products like paving and lubricants.

North Charleston is where we originally piloted the refining of oleos and other changes we have made at the site have freed up capacity, so we can use existing infrastructure to quickly begin refining soy, canola, and other oleo-based materials, with the added benefit of having post refinery derivatization capabilities on site in North Charleston.

The North Charleston site has both a refinery that runs CTO, but also a smaller secondary refinery, which we call the BNG. This refinery has approximately 25% to 30% of the capacity of Crossett and with modest investment, that capacity can be increased to 50% of Crossett's output and there is the ability to expand further as the need requires.

This capacity is enough to meet the perceivable demand for oleo growth. By operating both refineries on one site, we get the benefit of higher fixed cost absorption and we also save on the transport of oleo products from Crossett to Charleston where we derivatize them into finished goods.

Crossett's underutilization was causing a drag on the segment's earnings. Concurrent with the Crossett closure, we are reducing head count to adjust for the smaller physical footprint, with overall annual savings expected to be $30 million to $35 million beginning in 2025 when you account for both the closure in Crossett and reductions at corporate functions.

On Slide 7, you'll see a recap of our repositioning strategy, which is to reduce our exposure to low-margin cyclical end markets, diversify our raw material streams and optimize our physical footprint, all of which will create a more profitable and stable business segment.

By exiting the CTO contract, we have put this cash drain behind us and by the end of the first quarter of next year, we will be running the business with lower cost market price CTO, which will enhance both our profitability and competitive position in the market.

We said previously that 2024 was going to be a transition year for Performance Chemicals as we execute on this repositioning. While we always continue to assess how best to optimize our businesses, we believe most of the heavy lifting is now behind us to return this segment to profitability.

Now I'll turn it over to Mary to run through the financials for the quarter.

[Mary Hall, executive]

Thanks, John, and good morning, all. Please turn to Slide 8. Second quarter sales of $390.6 million were down 19% due primarily to our repositioning actions in Performance Chemicals, which included reducing our exposure to certain low margins end markets in the Industrial Specialties product line and continued weakness in industrial demand, which impacted both Industrial Specialties and APT. In addition, we saw lower sales in road technologies in the quarter due to adverse weather conditions in North America.

EBITDA margins improved 80 basis points to 26% as a strong quarter from Performance Materials more than offset lower margins in Performance Chemicals. During the quarter, we had $13 million of restructuring charges and $24 million of CTO resale losses related to the Performance Chemicals repositioning. We also booked a noncash goodwill impairment charge of $349 million for the Performance Chemicals segment, which was triggered when we received new information from our long-term supplier regarding CTO pricing for the second half of 2024, which was much higher than expected.

When performing the goodwill impairment testing, we updated the growth assumptions for all product lines in Performance Chemicals as required. The combination of current depressed financial performance and the continued weakness in industrial demand with limited indications of near-term recovery caused us to revise our growth expectations for Industrial Specialties end markets, including oleo markets and road marking, which is being negatively impacted by fierce competition in the paint space, which represents approximately half of our road markings product sales.

Our analysis indicated that the book value of the segment significantly exceeded fair value, resulting in a total impairment of Performance Chemicals recorded goodwill.

The goodwill charge of $349 million, the CTO losses of $24 million and the restructuring charges of $13 million are a combined total of $386 million of non-operating charges, which led to a GAAP net loss of $283.7 million. We've excluded the impact of these charges in our non-GAAP disclosure and our discussion for the remainder of this presentation. A reconciliation of our non-GAAP measures to GAAP is in the appendix to this deck and also in our earnings release in Form 10-Q, which will be filed this evening.

Our adjusted gross profit of $140.5 million declined 17% due primarily to lower sales in Performance Chemicals, while gross profit margin was higher by 80 basis points due to a combination of increased sales in Performance Materials, reduced exposure to lower margin end markets in Performance Chemicals and realized savings of $17 million related to the Performance Chemicals repositioning and other corporate actions taken last year.

Adjusted SG&A improved 16% year-over-year, which included realized savings of about $5 million related to last year's action. The total realized savings of $22 million in the quarter put us on track to achieve our target of $65 million to $75 million in annual savings from the combined restructuring actions taken last year.

Our diluted adjusted EPS and adjusted EBITDA dollars declined on the lower sales, but we delivered a strong adjusted EBITDA margin of 26%, reflecting the underlying strength of the company's core portfolio as we reposition Performance Chemicals. We estimate our 2024 tax rate will be between 23% and 25%.

Turning to Slide 9, I'll focus on leverage and free cash flow. We ended the quarter with reported leverage of about 4x and expect Q2 to be the peak leverage this year, as we noted in our last earnings call. Also, I want to point out that our leverage calculation for the prior 2 quarters changed as a result of guidance from the SEC to revise future filings to no longer exclude certain inventory charges from adjusted EBITDA.

We had excluded inventory write-downs of $19.7 million in Q4 of 2023 and $2.5 million in Q1 of 2024. These have now been included, therefore reducing adjusted EBITDA in those respective quarters. The appendix to the slide deck and the press release has the details of our leverage calculation. We expect leverage to decline through the second half of this year and to end the year at about 3.5x.

Our bank-calculated leverage was 3.3x at the end of Q2 and we are comfortably in compliance with all of our bank covenants.

Free cash flow for the quarter was $12 million, which includes the negative cash impact of $26 million of CTO resale losses and $13 million of restructuring charges. Without these, free cash flow would have been $50 million and on pace to exceed our original guidance for full year free cash flow of greater than $75 million.

Looking at the second half of the year, we have revised our guidance to include the $100 million CTO contract termination fee and approximately $10 million for primarily severance-related cash costs associated with the closure of the Crossett plant, resulting in updated free cash flow guidance from greater than $75 million to slightly positive for the full year. We have a table on our guidance slide, Slide 13 and it highlights the $155 million of cash drag from CTO resales and the termination fee that won't recur.

So let's turn to Slide 10 and you'll find results for Performance Materials. Sales were up 9% to $157.2 million and EBITDA was up 28% to $82.2 million, with an EBITDA margin of 52.3%. I always caution folks not to forecast a repeat in quarterly margins when it comes to this business, but after 4 quarters of 50%-plus margins, even I am ready to say that we expect full year margins for PM to be in the 50% area.

We had our normal scheduled downtime at the plant during the quarter and expect to have similar downtime the rest of the year. Input costs such as energy and certain raw materials were lower year-over-year, but a major driver of the improved EBITDA is the operational efficiencies John mentioned earlier.

Energy prices will fluctuate, but the team has made improvements at our plants such that we are consistently using less energy than before and we're seeing the results benefiting the bottom line. We believe this is a structural and sustainable cost improvement in the business. Over the long term, we continue to expect EBITDA margins in the mid to high-40%s.

Turning to Slide 11, revenue in APT was $47.9 million, down 10% as lower pricing in all regions offset higher volumes. Volumes were up nearly 5% year-over-year and this was also the third straight quarter of volume growth. Europe has seen a very strong rebound from last year's lows, while Asia, particularly China, continues to be weak, but we're seeing encouraging signs as the team focuses on higher margin opportunities in end markets such as electronics and auto that appear to be in the midst of a rebound. These efforts, along with lower energy costs and continued discipline in managing SG&A, contributed to the segment's 20% EBITDA margin.

Now please turn to Slide 12 for Performance Chemicals results. Sales of $185.5 million were down 35%, primarily due to the repositioning actions affecting the Industrial Specialties product line, which had sales dropped 60% to $56.4 million. On our last call, we indicated that we expected sales for Industrial Specialties to be about $65 million per quarter for the rest of the year, but given the muted industrial recovery expectations for the second half of this year, it's more likely that sales will be in the $50 million to $55 million range per quarter for the remainder of the year.

Road technology sales were down $11.8 million from a record quarter last year, attributed to weather-related delays in road construction projects. EBITDA for the segment was $9.3 million, down 79% due to significantly higher CTO costs and lower low-capacity utilization rates at our Crossett and North Charleston sites.

As John mentioned, this segment will be working through the existing high-cost CTO inventory for the remainder of the year and into Q1 of 2025, which will negatively impact margins these next 3 quarters. Given the many changes impacting this segment, we are sharing our expectation that segment EBITDA will be breakeven for full year 2024 with a return to profitability in 2025.

Our transformation of the Performance Chemicals segment into a more specialty-focused, less capital-intensive business is well underway and we expect to see the benefits beginning in second quarter of 2025, resulting in more profitable and stable financial performance.

And now I'll turn the call back to John for an update on guidance and closing comments.

[John Fortson, executive]

Thanks, Mary. Please turn to Slide 13. This has been a busy quarter at Ingevity. We discussed additional steps taken in our repositioning efforts. We discussed terminating our CTO contract. We discussed the slower sale of our oleo-based and inspect products in a weaker industrial market and weather delays impacting road tech.

Based on what we see at this point, industrial markets remain soft going into the second half of the year. More bad weather impacted road construction in July. Therefore, we are revising our full-year sales guidance to be between $1.4 billion and $1.5 billion and adjusted EBITDA guidance to be between $350 million and $360 million.

This reflects the uncertainty we have as to whether road crews have the time to make up the lost sales due to adverse weather, higher CTO costs and inventory affecting Performance Chemicals bottom line and a lack of an industrial recovery that could affect both APT and our oleo-based products in the Industrial Specialties line.

We can't control the weather, but we can control how we reposition our Performance Chemicals segment to deliver sustained profitability. We remain confident that Ingevity will emerge from 2024 stronger and better. There are nearly $200 million of outflows on that free cash flow table that won't be there next year. We are working to deliver mid- to high-20% margins on a consolidated basis and generate over $150 million a year in free cash flow, which we will use to delever the balance sheet and then return cash to shareholders.

With that, I'll turn it over to questions.

[Operator]

[Operator Instructions] We have the first question from John McNulty with BMO Capital Markets.

[John McNulty, analyst]

Obviously, a lot going on and a lot to unpack. So I guess the first thing I wanted to understand better is you're going to continue to have kind of the CTO high cost pressures through the first quarter and then they should drop off to kind of more market levels. If today's market was kind of what you see, whatever, say Q2 of next year, how much of a quarterly benefit would that be on the market pricing versus the stuff that you're working through in your inventory right now? How should we think about that?

[John Fortson, executive]

Yes. So John, probably the simplest way to think about that is I think we expect the price that we're paying for CTO in a given quarter is probably going to fall by half. It's going to be half, roughly. I mean, it's obviously the market will do what the market will do and we're talking about 9 months away, 8 months away. But our expectation, based on what we're seeing today and where the market is, is that starting in Q2 of 2025, first off, we're not buying any more off-market CTO now, right?

So the cash drain piece is nipped, right, or cauterized. So while we -- but we will be running, as we alluded to, this higher inventory CTO through our plants and therefore, through our P&L, right? But by second quarter of next year, we will be running a lower-cost CTO that we will be procuring in the open market and that cost should be about half of what we're paying today.

[Mary Hall, executive]

Assuming today's levels.

[John Fortson, executive]

Assuming today's levels. Yes, I mean, it may be better than that, candidly, but I don't -- I think half is probably the right way to think about it, right?

[John McNulty, analyst]

Okay. Got it. That's helpful. And then on the paving business, so it sounds like you lost, I don't know, somewhere in the neighborhood of $15 million to $25 million or so on wet weather or so and it sounds like that's going to also impact you in 3Q. So whatever, let's call it $40-plus million of revenue that may be getting pushed out.

I guess if that can't be made up this year, should we assume that that gets additive to next year, or is it with municipalities, it's kind of a -- look, you use your budget this year, you don't. If you don't, it's not like you get to push it to the following year, I guess. How should we be thinking about that? Because it does seem like a lot of high-value product for you that at least temporarily has been kind of sidelined.

[John Fortson, executive]

Well, so, I mean, a couple things on that question, right? And Rich is here, so you can chime in, Rich. But the weather, there's no doubt, we're having sort of a weird weather year, right? So the paving season got off -- and this has happened to us in the past, right? The paving season got off to a slow start, then it kind of fired back up, then we sort of had some weather in Texas in July, which has made July a little soft and we'll see what August, September holds.

There is -- as I alluded to in my comments, I mean, the pavers are incentivized to go as long as they can, right? And so to the extent the weather pattern shifts and we're able to pave later into the season, we may have a stronger-than-normal sort of first couple months of Q4. And we've seen that happen before, right? But it's too early to call and we are sort of having a strange weather year. So we're taking a prudent approach.

With regards to rollovers to next year, it has been our experience that funding is put in and pavers will roll back to the next year, meaning that they have a plan, they allocate money to it, they get it done, they don't get it done, it will bode well for next year because it will get pushed. But we also have to take that year-on-year, right? Because we have to see what the environment is. Directionally, interest in paving and efforts to continue to pave and spend on infrastructure remain strong. But that does -- that would be the normal pattern for us.

[John McNulty, analyst]

Got it. Okay. And if I could sneak in maybe one last one. The $30 million to $35 million that you expect to save from the Crossett rationalization, I guess, should we be thinking about that coming through evenly? Is it back-end loaded for 2025? I guess, how should we be thinking about that?

[John Fortson, executive]

Well, it's pretty even in the sense that the plant will cease operations here very shortly, right? So the full -- by the end of the year, the full benefits will be rolling through in 2025. Just to sort of build on the comments that were prepared, John, you can look at those numbers and obviously deduce that the fixed cost of trying to run that site -- because it is a refinery, so it needs high utilization to make it operate, right? And we are just basically taking an operating philosophy now that we're going to build it as we go, right?

So we were hopeful and I think in a stronger industrial environment thought that the utilization could pick up in that site quickly enough that we wouldn't need to take these actions. But what we're -- we were confronted with a choice of not knowing and having some uncertainty as to what the next couple of years' impacts could be from an earning perspective versus using an existing refinery -- it's a secondary refinery that we have in Charleston that for a very modest amount -- we're going to build it as we grow, right?

So as I alluded to in my comments, with very modest investment, we can kind of get 50% of the output of Crossett and we'll just make those capacity expansions as needed and we'll -- but we're not abandoning or changing the overall AFA approach.

[Operator]

We now have Daniel Rizzo with Jefferies.

[Daniel Rizzo, analyst]

Once you do the changes and move to North Charleston, what will be your capacity utilization for refining at that site?

[John Fortson, executive]

Well, we don't really always discuss this, but obviously it's going to improve, right, because we're moving utilization from Crossett to Charleston, but we have plenty of room to expand capacity both on the CTO and non-CTO -- CTO and oleo-based refining, right? So we feel comfortable that we can expand and produce going forward there.

And as I kind of alluded to, we can build as we grow back by making relatively modest changes to how we do things to expand that utilization, right? I mean, we will invest in Charleston as needed, but we can do it in a more capital-efficient manner versus the current footprint that we're sitting here today, right?

And I think it's important, as everyone on this call understands, I mean, we've gone from what was a 3-plant network down to a 1-plant network. And so the throughput and the absorption you're going to get on a consolidated basis by doing that is pretty significant. But that has to be done when you look at the changes in the cost structure that's happening in that business, right? And so that's the math and that's the work that we've been doing over the course -- well, it really started in November of last year, right?

[Daniel Rizzo, analyst]

So I mean, would you -- when you say just you can expand as needed, would that be just some simple, like, debottlenecking, or is it less than that? I mean, is it just -- I mean, obviously, there's...

[John Fortson, executive]

I mean, it's debottlenecking, it's piping. These are relatively modest things that, frankly, plants are always doing. But because this is a -- it's a very large site, one that we've operated for a long period of time, there's -- we have a pretty robust and pretty clear, this is what we spent the last 6, 9 months doing, sort of trying to lay out what this would look like.

[Daniel Rizzo, analyst]

Okay. And then finally, I think you mentioned that lower energy was a tailwind I think you said in Performance Materials. I was wondering what percentage of COGS energy is. Is it significant?

[John Fortson, executive]

It's very significant. I mean, beyond the raw material costs of basically sawdust and phosphoric acid, it is a big burner of natural gas, right? And it's a big explanation of what's been transpiring in that margin.

[Operator]

Your next question comes from Jonathan Tanwanteng with CJS Securities.

[Jonathan Tanwanteng, analyst]

Wanted to focus on the outperformance in the materials business, which has really been fantastic. I heard the commentary on the margins, which is great, but I was wondering if you could speak to the revenue run rate and if that is sustainable going forward. Do you think hybrid and ICE cars continue to, I guess, sustain that kind of revenue run rate, or is there more of a resumption of other, I guess, challenges as EV and other things pick up in the second half and through the near future?

[John Fortson, executive]

So -- and Ed's sitting next to me, so he can chime in as appropriate. I think we feel pretty good that the revenue environment that we're operating in today is going to be around for a while, right? And we feel good, as Mary alluded to in her prepared comments, certainly about the remainder of 2024, but I think we feel good in a more extended period.

And I would refer you back to the prepared comments because what's really going on here, John, and it's -- I know there's lots of puts and takes with auto production and then what is a hybrid versus what is an all-electric, but simply put, what's really happening here is the value that that business is getting towards products, right, coupled with the cost savings that that team has put in and as we alluded to, I mean, a number of these are structural, right?

We are using less energy. This is a -- these are basically large kilns, right? So they're burning a lot of natural gas, right? Those 2 things are more than offsetting effectively softness of auto production and that's kind of bouncing around depending on what region you're in or what have you and the adoption of all-electric vehicles, because remember, we are on hybrids, right? And I think our strategy will be to continue to pull the levers that we have to deal with the puts and takes of the auto industry. And we do feel very good though, certainly about the remainder of this year and in the next couple of years.

[Jonathan Tanwanteng, analyst]

And then just within the guidance, are you expecting any sequential improvements in pavement, number one? And number two, are you including any restructuring savings in this year? I know you said, 30 to 35 next year, but seeing as this plan is closing in 20, in August, are you realizing something Q3 and Q4?

[John Fortson, executive]

Yes. So I mean, it is August, right? Also, I'll take the last part first. By the time these closures occur over the next couple of months, the ability to really significantly impact 2024 is fairly modest, right? But there will be some, but pretty modest, right? Because you're talking about something really starting to see it sometime in Q4, right, by the time you sort of get all this done, right?

With regards to paving, you know us well enough, Jon. We tell it as we see it, right? And we try to be as transparent as we can. We had a weak start to the year. We had a weak first month, good 2 months, right? Now we've had kind of a weak July. We are going ahead and talking about that because it's true. And people saw the storms, right? We'll see what August and September holds. And then we'll see what happens in October and November, right?

Because this has happened to us in the past. It's not a normal year, but if the weather holds, the pavers will go into the fourth quarter as long as they can to make up for this lost business, right? But if the weather doesn't hold, then they can't. And then those projects will get pushed into next year. So that's an assumption we can't make, right? So we are taking a conservative position based on what we know and we'll see how the year pans out.

[Operator]

[Operator Instructions] And we now have Mike Sison with Wells Fargo.

[Michael Sison, analyst]

What's the run rate sales for Performance Chemicals as we head into 2025? Is it a $600 million business, $500 million business? Just trying to figure out kind of how that sort of shakes out with the restructuring.

[John Fortson, executive]

Well, we're not -- Mike, we're not -- it's the 1st of August, right? So we're not really talking about -- and I understand that people want to look beyond this. And so what we're saying is, is that as we've sort of been clear all year, this is the year we're going to fix this business so that we can emerge stronger in 2025. What I would tell you is, is that the sales impact of shutting Crossett is going to be relatively de minimis, right? Because we're transferring all that to Charleston, right?

So I would encourage you to look at thinking about the quarters of this year and making some annualization because really what we've done, we don't have to rid of this year. We've been operating with Charleston and Crossett and Crossett was not a revenue generator per se. So you can -- and those revenues will transfer, right? We're not losing. So I would encourage you to think about what the annualization looks like for '24, right, is the baseline for what '25 would be.

[Michael Sison, analyst]

Got it. And then, I mean, I get it. I mean, it's probably a tough question, but what gives you confidence that as we head into second quarter '25, that when you need CTO supply, that prices will be better than what they are now? I know it's a tough question, sorry.

[John Fortson, executive]

There's really 2 things, right, that I would point you to. You could argue a third, but one is we know with great clarity and I recognize we don't disclose this to the broader market, but we know with tremendous clarity how far off the prices we've been paying our supplier were with what was available in the market, meaning what we were buying or could have bought from other parties, what we believe our competitors were buying it at, what transactions we're seeing in that market, right? We know some of that because we were selling CTOs, right? So we know, right?

Now we alluded to this earlier and as I said, that benefit should be half is probably a good place to start, right? Now you say to yourself and I understand this, okay, well, the market is the market. What makes you feel confident the market will stay? It may move around, but we've got a lot of playroom for where we were, right? What I would also say is we're in a weak economic environment, right? And so demand is not as robust as it can be. The biofuels industry is not consuming as much yet as what could arise at some point. So their demand for this product is relatively muted, right?

And over the last however many months, by terminating these contracts and by closing -- first by moving Crossett to a AFA-based plant and then shutting DeRidder, we've eliminated 200 plus thousand tons of demand for this stuff that used to be in the marketplace, right? So supply/demand economics would tell you that the price for CTO should remain relatively muted.

Now there is a new source of demand with the biofuel stuff, but that demand it seems is pretty known, right? And is relatively muted. So I think we can state with some comfort, although nothing is certain, but we're going to benefit next year from 2 things. One is we're going to have a reduced cost structure, which we've pointed to today. First was what we did in DeRidder in November.

Now is what we've announced today. And that has some real value. And you can look at the math of what we disclosed. And then we've told you that our CTO costs should come down a lot. So this is all a part of getting this business back to profitability and positive cash generation. But that footprint are done. I mean, we're now to one site, right? So those things are -- that's happened.

[Michael Sison, analyst]

Right. And then, so I guess final question, just if I think about Industrial Specialties as it is going forward, what do you need to see in terms of profitability, returns? It's a fairly small business now relative to the portfolio. And I guess, is there a hurdle rate where you need to get to where -- and if you don't, is it potential that you have to either divest it or move on from the business? Or is there at least a fundamental reason you think that this will be a good business longer term?

[John Fortson, executive]

Well, listen, we always reserve the right, as we've said, to assess the portfolio and make adjustments to optimize Ingevity, right? I mean, we've got a business that even with all this noise has EBITDA margins at like 26%, right? So we want to get this cash position. To me, that's been a problem, right? I mean, we're relatively highly levered in today's market and our cash generation has been impacted by this. So we have cauterized that and can move forward starting to generate cash again and get that debt back down, right?

So the -- what I would tell you is, is that we're focused on getting this business back to what we would call a acceptable level of profitability. And I've laid out for you all the structural things that will happen with reduced footprint costs and with CTO savings. And then we'll make -- we need to then factor in the market itself, right? So is this a 2022 market? It is not, right?

This is not a post-COVID balance market. But the -- and the industrial markets, at least this year, have remained relatively benign and we're not talking '25, we'll have to see, right? I mean, I was reading yesterday, there's talk of rate cuts and other things. So we'll see where that goes. But our focus is let's get the cash generation, let's stop that bleeding and reverse it back to a more normalized footprint. And then let's get this business back to acceptable levels of profitability.

[Operator]

I would like to hand it back to John Nypaver for some final remarks.

[John Nypaver, executive]

Thanks, Brika. Thanks, everyone, for joining us. That concludes our call and we'll speak with you again next quarter.

[Operator]

Thank you all for joining the Ingevity second quarter 2024 earnings call and webcast. Please enjoy the rest of your day and you may now disconnect from the call.